top of page

PROGRAMME   EHMSG Workshop

Friday, September 13, 2024

 

08.25 – 08.30 hrs | Welcome by EHMSG President José Machado

08.30 – 10.30 hrs | Session 1:  Hot topics in H.pylori and gut microbiota

08.30 – 08.50 hrs                

1.1. Gut virome in inflammatory bowel disease and beyond

tba

08.50 – 09.10 hrs                

1.2. The person-to-person transmission landscape of the gut and oral microbiomes

Vitor Heidrich, Italy

09.10 – 09.30 hrs                

1.3. New drugs targeting H. pylori envelopes

Ivo Boneca, France

09.30 – 09.50 hrs                

1.4. Evolving concepts in H. pylori management

Shailja Shah, United States

09.50 – 10.10 hrs                

1.5. CAR-T Therapy & Microbiome

tba

10.10 – 10.30 hrs                

1.6. Evolution of the prevalence and incidence of Helicobacter pylori infection

Jyh-Ming Liou, Taiwan

10.30 – 11.00 hrs | Coffee Break

 

11.00 – 12.45 hrs | Session 2: News on gastritis (Parallel Session)

11.00 – 11.20 hrs                

02.01 The RE.GA.IN consensus project

Massimo Rugge, Italy

11.20 – 11.40 hrs                

02.02 Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients

Ludovica Bricca, Italy

11.40 – 12.00 hrs                

02.03 Trends in the prevalence of atrophic gastritis and Helicobacter pylori in Far East

Yoshio Yamaoka, Japan

12.00 – 12.15 hrs                

Talk from submitted abstracts

12.15 – 12.30 hrs                

Talk from submitted abstracts

12.30 – 12.45 hrs                

Talk from submitted abstracts

 

11.00 – 12.45 hrs |Session 3: Microbiome mechanisms of action (Parallel Session)

11.00 – 11.20 hrs                

03.01 Protein fermentation products and health outcomes

Silvio Waschina, Kiel, Germany

11.20 – 11.40 hrs                

03.02 Mechanisms of microbiome engraftment

Gianluca Ianiro, Italy

11.40 – 12.00 hrs                

03.03 Mycobiome in IBD

Petra Bacher, Germany

12.00 – 12.15 hrs                

Talk from submitted abstracts

12.15 – 12.30 hrs                

Talk from submitted abstracts

12.30 – 12.45 hrs                

Talk from submitted abstracts

 

12.45 – 14.00 hrs | Lunch Break & Poster Viewing

 

14.00 – 15.00 hrs | Session 4: Industry-Sponsored Satellite Symposium

15.00 – 16.45 hrs | Session 5: Helicobacter pylori: Genetics and Beyond (Parallel Session)

15.00 – 15.20 hrs                

05.01 Differences in H. pylori population structures worldwide

Kaisa Thorell, Sweden

15.20 – 15.40 hrs                

05.02  H. pylori evolution depends on niche specific physiological conditions

Sebastian Suerbaum, Germany

15.40 – 16.00 hrs                

05.03 Impact of H. pylori on mucosal immunity and colorectal cancer

Markus Gerhard, Germany

 

16.00 – 16.15 hrs                

Talk from submitted abstracts

16.15 – 16.30 hrs                

Talk from submitted abstracts

16.30 – 16.45 hrs                

Talk from submitted abstracts

 

15.00 – 16.45 hrs | Session 6: Oncobiome (Parallel Session)

                                            

15.00 – 15.20 hrs                

06.01 Microbiome mediated inflammation in colon cancer

Mathias Chamaillard, Lille, France

15.20 – 15.40 hrs                

06.02 Predicting CRC survival post-surgical resection using tumour microbial profiling

James Alexander, United Kingdom

15.40 – 16.00 hrs                

06.03 Microbiota-modulated immune checkpoint

Carolina Alves Costa Silva, France

16.00 – 16.15 hrs                

Talk from submitted abstracts

16.15 – 16.30 hrs                

Talk from submitted abstracts

16.30 – 16.45 hrs                

Talk from submitted abstracts

 

16.45 – 17.15 hrs | Coffee Break

 

17.15 – 19.00 hrs | Session 7: Gastric Carcinogenesis (Parallel Session)

17.15 – 17.35 hrs                

07.01 Microbiome and gastric cancer

Ceu Figueiredo, Portugal

 

17.35 – 17.55 hrs                

07.02 Innocent Bystander as a Precancerous Condition for Gastric Cancer?

Ken Sugano, Japan

17.55 – 18.15 hrs                

07.03 Natural History of Sporadic and Hereditary Diffuse Gastric Carcinoma: From Onset to Progression

Fatima Carneiro, Portugal

 

18.15 – 18.30 hrs                

Talk from submitted abstracts

18.30 – 18.45 hrs                

Talk from submitted abstracts

18.45 – 19.00 hrs                

Talk from submitted abstracts

 

17.15 – 19.00 hrs | Session 8: FMT session (Parallel Session)

17.15 – 17.35 hrs                

08.01 Safety in FMT

Josbert Keller, Netherlands

17.35 – 17.55 hrs                

08.02 Regulation of FMT and donor screening

Christian Hvas, Denmark

                                            

17.55 – 18.15 hrs                

08.03 How to improve FMT success

Alexander Link, Germany

 

15.15 – 18.30 hrs                

Talk from submitted abstracts

18.30 – 18.45 hrs                

Talk from submitted abstracts

18.45 – 19.00 hrs                

Talk from submitted abstracts

 

20.00 hrs                             

EHMSG Conference Dinner


 

Saturday, September 14, 2024

 

08.30 – 09.15 hrs | Session 9: Memorial Talks

08.30 – 08.45 hrs                 

09.01 In Memoriam Ashley Price

Anthony Axon, United Kingdom

                                            

08.45 – 09.00 hrs                

09.02 In Memoriam Pentti Sipponen

Ari Ristimäki, Finland

 

09.00 – 09.15 hrs                

09.03 In Memoriam Adrian Lee

Jim Fox, United States

09.15 – 11.00 hrs | Session 10: H. pylori management (Parallel Session)

09.15 – 09.35 hrs                

10.01 Current role of tailored therapy in treating H. pylori infection

Theodore Rokkas, Greece

09.35 – 09.55 hrs                

10.02 The rebirth of Bismuth in H. pylori eradication

Rocco Maurizio Zagari, Italy

09.55 – 10.15 hrs                

10.03 Latin American Registry on the Management of H. pylori Infection (Hp-LATAMReg)

Arnoldo Riquelme, Chile 

10.15 – 10.30 hrs                

Talk from submitted abstracts

10.30 – 10.45 hrs                

Talk from submitted abstracts

10.45 – 11.00 hrs                

Talk from submitted abstracts

09.15 – 11.00 hrs | Session 11: Probiotics (Parallel Session)

09.15 – 09.35 hrs                

11.01 Use of probiotics in chronic liver diseases

Luca Miele, Italy

09.35 – 09.55 hrs                

11.02 Inflammatory bowel diseases: when can probiotics be helpful?

Loris Lopetuso, Italy

09.55 – 10.15 hrs                

11.03 New probiotics: where is the future?

tba

10.15 – 10.30 hrs                

Talk from submitted abstracts

10.30 – 10.45 hrs                

Talk from submitted abstracts

10.45 – 11.00 hrs                

Talk from submitted abstracts

11.00 – 11.30 hrs | Coffee Break

 

11.30 – 13.30 hrs | Session 12: Debates – Gastric cancer screening

11.30 – 11.50 hrs                

12.01 Optimal strategies for gastric cancer screening – targeted vs. population based

Iris Lansdorp Vogelaar, Netherlands

11.50 – 12.10 hrs                

12.02 What is the optimal age for screening?

Jan Bornschein, United Kingdom

12.10 – 12.30 hrs                

12.03 Is there a role for endoscopy and AI in gastric cancer screening

Mario Dinis Ribeiro, Portugal

12.30 – 12.50 hrs                

10.04 Gastric cancer screening experience in Japan

Hidekazu Suzuki , Japan

12.50 – 13.10 hrs                

10.05 Helicobacter pylori Treatment and Gastric Cancer Risk After Endoscopic Resection of Dysplasia: A                     Nationwide Cohort Study

Hae Won Yoo, Korea

 

13.10 – 13.30 hrs                

10.06 Linqu county study status

Wen Qing Li, China

13.30 – 15.00 hrs | Lunch Break & Poster Viewing

 

15.00 – 17.00 hrs |Session 13: Updates in Helicobacter & Microbiota

15.00 – 15.20 hrs                

13.01 Million Microbiome from Humans Project

Lars Engstrand, Sweden

15.20 – 15.40 hrs                

13.02 Machine Learning for Microbiome analysis

tba

15.40 – 16.00 hrs                

13.03 Differential responses of the gut microbiome and resistome to antibiotic exposures in infants and adults

tba

16.00 – 16.20 hrs                

13.04 The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection

Cristina Martins, Portugal

16.20 – 16.40 hrs                

13.05 Novel principles for cure of H. pylori infection

Peter Malfertheiner, Germany

16.40 – 17.00 hrs                

13.06 Histamine Signaling Is Essential for Tissue Macrophage Differentiation and Suppression of Bacterial Overgrowth in the Stomach Cell

Ki Taek Nam, Korea

      

17.00 – 18.00 hrs | Session 14: Closing Session

17.00 – 17.20 hrs                

14.01 Awarding of the Marshall and Warren Medal 2024 to Fatima Carneiro, Porto, Portugal

17.20 – 17.35 hrs

14.02 Awarding of the EHMSG Oral and Poster Awards

17.35 – 17.50 hrs

14.03 Presentation of the EHMSG Journal

Francesco Franceschi, Italy

17.50 – 18.00 hrs                

14.04 Presentation of the next meeting in Rome

Closing Remarks

bottom of page